Fetal tissue implant
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Fetal tissue implant or fetal cell therapy is implanting tissue from a fetus to a patient for treatment of disease. In the case of Parkinson's disease, it is hoped that the fetal tissue would produce chemicals, specifically dopamine, lacking in the diseased brain. Treatment was also studied for Alzheimer's and Huntington's. Fetal tissue is unique in its fast growing and low immune system rejection possibility.
Because the source of the tissue is aborted fetuses, there are significant legal and ethical issues being discussed. Federal funding for embryonic tissue was restricted in the United States under Presidents Ronald Reagan and George H. W. Bush before being lifted under the Clinton administration.